Literature DB >> 16406668

mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat.

Jun-Yang Wang1, Xiao-Yan Zeng, Gui-Xiang Fan, Yu-Kang Yuan, Jing-Shi Tang.   

Abstract

Previous studies have indicated that interferon-alpha (IFN-alpha) can bind to opioid receptors and exerts an antinociceptive effect in both peripheral and central nervous systems. The current study investigated the antinociceptive effect of IFN-alpha unilaterally microinjected into the thalamic nucleus submedius (Sm) of rats on noxious thermal stimulus, and the roles of different subtypes of opioid receptors in mediating the Sm IFN-alpha-evoked antinociception. The results indicated that unilateral microinjection of IFN-alpha (4, 8, 16 pmol) into the Sm dose-dependently increased the hind paw withdrawal latency from the noxious heat stimulus, and this effect was reversed by pretreatment with non-selective opioid receptor antagonist naloxone (200 pmol) and specific mu-opioid receptor antagonist beta-FNA (1 nmol) into the same sites, whereas delta-opioid receptor antagonist ICI174,864 (1 nmol) and kappa-opioid receptor antagonist nor-BNI (1 nmol) failed to alter the effect of IFN-alpha. These results suggest that Sm is involved in IFN-alpha-evoked antinociception and mu- but not delta- and kappa-opioid receptor mediates the Sm IFN-alpha-evoked antinociception.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406668     DOI: 10.1016/j.neulet.2005.12.046

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Short small-interfering RNAs produce interferon-α-mediated analgesia.

Authors:  P H Tan; Y J Gao; T Berta; Z Z Xu; R R Ji
Journal:  Br J Anaesth       Date:  2012-02-03       Impact factor: 9.166

2.  Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.

Authors:  Jennifer C Felger; Oyetunde Alagbe; Fang Hu; Deborah Mook; Amanda A Freeman; Mar M Sanchez; Ned H Kalin; Emiliangelo Ratti; Charles B Nemeroff; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2007-08-02       Impact factor: 13.382

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

Review 5.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

Review 6.  Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Authors:  Jennifer C Felger; Andrew H Miller
Journal:  Front Neuroendocrinol       Date:  2012-09-21       Impact factor: 8.606

Review 7.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

Review 8.  Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.

Authors:  Jennifer C Felger
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders.

Authors:  K T Weber; Shina Satoh; D Olivier Alipui; Justin Virojanapa; Mitchell Levine; Cristina Sison; Shaheda Quraishi; Ona Bloom; Nadeen O Chahine
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

10.  Interferon alpha inhibits spinal cord synaptic and nociceptive transmission via neuronal-glial interactions.

Authors:  Chien-Cheng Liu; Yong-Jing Gao; Hao Luo; Temugin Berta; Zhen-Zhong Xu; Ru-Rong Ji; Ping-Heng Tan
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.